Back to search results
NCT07636434

My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis

Not Yet Recruiting
NAAges 18+InterventionalTreatment
University of Washington
~110 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:My MS Toolkit

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Depressive Symptom Severity
Measured over Baseline (prior to treatment), 12-week and 4-month

Conditions

Multiple Sclerosis
Multiple Sclerosis (MS)

Explore related trials

DepressionMultiple Sclerosis

NCT07636434

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Washington

    Seattle, Washingtonstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Dawn M Ehde, PhD · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

Susan Robles
[email protected]
206-598-0501
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-reported diagnosis of MS (with screening questions such as current disease modifying therapy)
At least 18 years of age
Can read, write, and speak in English
Score of \>4 on the Patient Health Questionnaire, indicating at least mild depressive symptoms
Have access to an internet-connected device for accessing the intervention

Exclusion

Previous diagnosis of bipolar disorder or schizophrenia
Started medication for depression or anxiety in the past 2 months
Currently undergoing psychotherapy for depression
Are of moderate or high risk for suicide on the Columbia Suicide Severity Rating Scale (C-SSRS)
Participating in another clinical trial

What this trial measures

  • Depressive Symptom SeverityBaseline (prior to treatment), 12-week and 4-month

    This will be measured using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 Depression 8a. Change from pre- to post-treatment will be measured and compared between My MS Toolkit and usual care participants. Responses from each item will be summed to form a total raw score ranging from 4-20. Higher scores indicate higher self-reported levels of depressive symptoms.